fludarabine,cyclophosphamide,allo-316,allo-647
allogene therapeutics
['renal,(-adrenal)', 'allo-316', 'allogene therap']
allogene therapeutics presents interim phase 1 data on allo-316 in renal cell carcinoma at the american association of cancer research (aacr) annual meeting #stocksoftheday #stockalert #stocknews #cancer #event #newclinicaltrialdata #phase1 
Find the most important news and press releases about U.S. publicly-traded companies in real-time and stay ahead of the game!